Rationale and design of the national emphysema treatment trial (NETT): A prospective randomized trial of lung volume reduction surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 118, Issue 3, 1999, Pages 518-528

  Piantadosi, S ^a   Rodarte, J ^a   Miller III, C ^a   Barnard, P ^a   Carter, J ^a   Dubose, K ^a   Flanigan, T ^a   Fox, P ^a   Haddad, J ^a   Hale, K ^a   Jahn, A ^a   King, K ^a   Nguyen, C ^a   Norman, S ^a   Officer, T ^a   Reardon, M ^a   Ricketts, J ^a   Sax, S ^a   Tucker, M ^a   Williams, K ^a   Sugarbaker, D ^a   Fanning, C ^a   Birkenmaier, K ^a   Body, S ^a   Catanzano, C ^a   Duffy, S ^a   Formanek, V ^a   Fuhlbrigge, A ^a   Hartigan, P ^a   Hunsaker, A ^a   Jacobson, F ^a   Mark, L ^a   Russell, R ^a   Saunders, D ^a   Simons, G ^a   Swanson, S ^a   McKenna, R ^a   Mohsenifar, Z ^a   Geaga, C ^a   Aberle, D ^a   Brown, J ^a   Clark, S ^a   Cooper, C ^a   Ferrill, R ^a   Frantz, R ^a   Gelb, A ^a   Goldin, J ^a   Gordon, J ^a   Head, D ^a   Joyner, M ^a   Julien, P ^a   Levine, M ^a   Lewis, M ^a   Pendio, M ^a   Silverman, J ^a   Walker, P ^a   Williams, B ^a   Yegyan, V ^a   Yoou, C ^a   Maurer, J ^a   DeCamp, M ^a   Meli, Y ^a   Aviv, L ^a   Hearn, C ^a   Kraenzler, E ^a   Marlow, S ^a   McCarthy, K ^a   Mehta, A ^a   Meziane, M ^a   O'Donovan, P ^a   Schilz, R ^a   Sullivan, E ^a   Ginsburg, M ^a   Scharf, S ^a   Jellen, P ^a   Asegu, A ^a   Austin, J ^a   Bartels, M ^a   Berkman, Y ^a   Berkoski, P ^a   Brogan, F ^a   Delphin, E ^a   Demercado, G ^a   DiMango, A ^a   DePrisco, L ^a   Gonzales, J ^a   Gotthelf, J ^a   Herman, P ^a   Khan, A ^a   Mantinaos, M ^a   McKeon, K ^a   Mets, B ^a   Pearson, G ^a   Pfeffer, J ^a   Rossoff, L ^a   Sunshine, A ^a   Simonelli, P ^a   Stavrolakes, K ^a   Thomashow, B ^a   more..

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MUCOLYTIC AGENT; NARCOTIC AGENT; OXYGEN; STEROID; THEOPHYLLINE;

ARTICLE; CARBON DIOXIDE LASER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COUNSELING; ECHOCARDIOGRAPHY; EMPHYSEMA; EXERCISE; HUMAN; INFLUENZA VACCINATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG SCINTISCANNING; LUNG TRANSPLANTATION; LUNG VOLUME; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; OXYGEN THERAPY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SMOKING CESSATION; THORAX RADIOGRAPHY; WALKING;

EID: 0032886295     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70191-1     Document Type: Article

References (41)

1. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am Rev Respir Crit Care Med 152 1995 S77 S121
2. American Lung Association Lung disease data, 1993 1993 American Lung Association, New York 33
3. NM Siafakas P Vermeire NB Pride Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force Eur Respir J 8 1995 1398 1420
4. 1 . The Lung Health Study J Am Med Assoc 272 1994 1497 1505
5. Centers for Disease Control Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 46 RR-9 1997 1 25
6. Centers for Disease Control Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 46 RR-08 1997 1 24
7. AL Ries Chronic obstructive pulmonary disease 3rd ed WN Kelley HL DuPont JH Glick Textbook of internal medicine 1997 : Lippincott-Raven Philadelphia 1979 1984
8. S Saint S Bent E Vittinghoff D Grady Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis JAMA 273 1995 957 960
9. PW Jones TK Bosh Quality of life in COPD patients treated with salmeterol Am J Respir Crit Care Med 155 1997 1283 1289
10. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines Chest 112 1997 1363 1396
11. 1 decline in individuals with severe deficiencies of alpha-1-antitrypsin Am J Crit Care Med 158 1998 49 59
12. Y Lacasse E Wong GH Guyatt Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease Lancet 348 1996 1115 1119
13. AL Ries Rehabilitation in chronic obstructive pulmonary disease and other respiratory disorders ed 3 AP Fishman Pulmonary diseases and disorders 1997 : McGraw-Hill New York 709 719
14. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial Ann Intern Med 93 1980 391 398
15. Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 1 1981 681 686
16. TL Petty The National Mucolytic Study: results of a randomized double-blind, placebo controlled study of iodinated glycerol in chronic obstructive bronchitis Chest 97 1990 75 83
17. American Thoracic Society Guidelines for the approach to the patient with severe hereditary alpha-1 antitrypsin deficiency Am Rev Respir Dis 140 1989 1494 1497
18. J Deslauriers History of surgery for emphysema Semin Thorac Cardiovasc Surg 8 1996 43 51
19. OC Brantigan E Mueller Surgical treatment of pulmonary emphysema Am Surg 23 1957 789 804
20. A Wakabayashi M Brenner RA Kayaleh Thoracoscopic carbon dioxide laser treatment of bullous emphysema Lancet 337 1991 881 883
21. JD Cooper EP Trulock AN Triantafillou Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease J Thorac Cardiovasc Surg 109 1995 106 116
22. RJ McKenna Jr M Brenner AF Gelb A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema J Thorac Cardiovasc Surg 111 1996 310 322 (with discussion)
23. RJ McKenna Jr M Brenner RJ Fischel AF Gelb Should lung volume reduction surgery be unilateral or bilateral? J Thorac Cardiovasc Surg 112 1996 1331 1339 (with discussion)
24. R Bingisser A Zollinger M Hauser Bilateral volume reduction surgery for diffuse pulmonary emphysema by video-assisted thoracoscopy J Thorac Cardiovasc Surg 112 1996 875 882
25. JD Cooper GA Patterson RS Sundaresan Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema J Thorac Cardiovasc Surg 112 1996 1319 1330 (with discussion)
26. JI Miller Jr RB Lee KA Mansour Lung volume reduction surgery: lessons learned Ann Thorac Surg 61 1996 1464 1469 (with discussion)
27. TM Daniel BK Chan V Bhaskar Lung volume reduction surgery: case selection, operative technique, and clinical results Ann Surg 223 1996 526 533 (with discussion)
28. M Argenziano N Moazami B Thomashow Extended indications for volume reduction pneumoplasty in advanced emphysema Ann Thorac Surg 62 1996 1588 1597
29. W Wisser E Tschernko O Senbaklavaci Functional improvement after volume reduction: sternotomy versus videoendoscopic approach Ann Thorac Surg 63 1997 822 828 (with discussion)
30. Health Care Financing Administration Report to Congress. Lung volume reduction surgery and Medicare coverage policy: implications of recently published evidence 1998 . Department of Health and Human Services Washington (DC)
31. JE Ware Jr M Kosinski MS Bayliss Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study Med Care 33 4 Suppl 1995 AS264 AS279
32. RM Kaplan JP Anderson The general health policy model: an integrated approach B Spilker Quality of life and pharmacoeconomics in clinical trials 1996 . Raven New York 309 322
33. PW Jones FH Quirk CM Baveystock P Littlejohns A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321 1327
34. EG Eakin PM Resnikoff LM Prewitt AL Ries RM Kaplan Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire Chest 113 1998 619 624 University of California, San Diego
35. GAV Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
36. JGW Burdon EF Juniper KJ Killian The perception of breathlessness in asthma Am Rev Respir Dis 126 1982 825 828
37. B Steele Timed walking tests of exercise capacity in chronic cardiopulmonary illness J Cardiopulm Rehabil 16 1996 25 33
38. RM Reitan Validity of the trail making test as an indicator of organic brain damage Percept Mot Skills 8 1958 271 276
39. RM Reitan Trail Making Test: manual for administration and scoring 1992 : Reitan Neuropsychology Laboratory Tucson
40. L Goldman DL Caldera SR Nussbaum Multifactorial index of cardiac risk in non cardiac surgical procedures N Engl J Med 297 1977 845 850
41. JH Shih Sample size calculation for complex clinical trials with survival endpoints Control Clin Trials 16 1995 395 407